Apollo Medical Holdings, Inc. (AMEH) CEO Brandon Sim on Q1 2022 Results - Earnings Call Transcript

SA Transcripts
154.12K Followers

Q1: 2022-05-05 Earnings Summary

EPS of $0.31 misses by $0.01

Apollo Medical Holdings, Inc. (AMEH) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET

Company Participants

Carolyne Sohn – Investor Relations
Brandon Sim – Co-Chief Executive Officer
Eric Chin – Chief Financial Officer
Chan Basho – Chief Strategy Officer & Interim Chief Financial Officer

Conference Call Participants

Operator

Greetings. Welcome to the Apollo Medical Holdings First Quarter 2022 Financial Results. [Operator Instructions] Please note this conference is being recorded.

I will now turn the conference over to your host, Carolyne Sohn of The Equity Group. You may begin.

Carolyne Sohn

Thank you, operator, and hello everyone. Thank you for joining us.

The press release announcing Apollo Medical Holdings Inc.'s results for the first quarter ended March 31, 2022 is available at the Investors section of the company's website at www.apollomed.net. To provide some additional background on its results the company has made a supplemental deck available on its website. A replay of this broadcast will also be made available at ApolloMed's website after the conclusion of this call. Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contains certain forward-looking statements within the meaning of the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.

These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook and will and include, among other things, statements regarding the company's guidance for the year ending December 31, 2022, continued growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans and merger integration efforts as well as the impact of the 2020 novel coronavirus or COVID-19 pandemic and other variants on the company's business, operations and financial results.

Although the company believes

Recommended For You

About ASTH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ASTH